BioRestorative Therapies(BRTX) - 2025 Q2 - Quarterly Results

Form 8-K Current Report Item 2.02: Result of Operations and Financial Condition BioRestorative Therapies, Inc. announced Q2 2025 financial results via a press release on August 12, 2025, which is furnished, not filed, under the Securities Exchange Act - The company announced its financial results for the second quarter ended June 30, 2025, through a press release issued on August 12, 2025[3] - The press release, furnished as Exhibit 99.1, also contained a business update and information regarding a conference call to discuss the results[3] - The information furnished under this item, including Exhibit 99.1, is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless explicitly stated[5] Item 7.01: Regulation FD Disclosure This section clarifies that the press release information is furnished under Regulation FD, not filed, and is not automatically incorporated by reference or deemed material - The information provided in the press release is being furnished, not filed, and will not be incorporated by reference into any registration statement unless specifically identified[6] - The company states that furnishing the information does not mean it is material, complete, or necessary for an investment decision[6] Item 9.01: Financial Statements and Exhibits This section lists the exhibits filed with the Form 8-K, including the Q2 2025 financial results press release and the interactive data file Exhibits Filed | Exhibit Number | Description | | :--- | :--- | | 99.1 | Press release, dated August 12, 2025, issued by BioRestorative Therapies, Inc. | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | Signatures The report was officially signed and authorized by Robert Kristal, Chief Financial Officer of BioRestorative Therapies, Inc., on August 12, 2025 - The report was signed on behalf of the company by Robert Kristal, Chief Financial Officer[11] - Date of signature: August 12, 2025[11]